Published July 12, 2024
| Version v1
Data paper
Open
Decoding the immune checkpoint signatures in human atherosclerosis: implications of type 2 diabetes and lipid-lowering intervention
Creators
Description
| Immune checkpoint inhibitor (ICI) therapies in cancer accelerate atherosclerosis progression. Here, we have charted the landscape of immune checkpoint gene expression and defined the network of disease-relevant interactions with single-cell resolution. We found that signaling through PD-1 and CTLA4 is driven by a population of dendritic cells enriched for FSCN1 that can be derived from peripheral blood cells following anti-PD-1 or -CTLA4 treatment ex vivo. Type 2 diabetes dampened plaque PD-1 and CTLA4 signaling, showing that cardiometabolic comorbidities elicit unique responses to ICIs. Lipid-lowering therapy equalized the intensity and direction of immune checkpoint interactions in human blood, while atherosclerotic mice subjected to a lipid-lowering diet displayed both increased co-inhibitory signaling and a downregulation of inflammatory transcriptional programs in plaques. Our findings underscore the potential of lipid-lowering therapies in stabilizing immune checkpoint interactions and reducing plaque inflammation, offering new insights on atherosclerosis and cardiovascular risks in cancer patients undergoing ICI treatments. |
Files
Files
(57.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:cc08edc64531f0fc203c2847ad11ff28
|
2.9 MB | Download |
|
md5:74c8bf8d720cb6f38d0792d1b9678523
|
1.1 MB | Download |
|
md5:e32ea41472b672e339219d986b595193
|
37.9 kB | Download |
|
md5:a43f12a55fe6153a2c3bfc5d5db4a1b9
|
187.3 kB | Download |
|
md5:fe2a08350a4f75efb374e5a91c4744a1
|
1.9 MB | Download |
|
md5:78f355d59dba5aad7db9323ac79045f0
|
102.6 kB | Download |
|
md5:9b3edf2804d32e8c134898318e5115fc
|
407.7 kB | Download |
|
md5:79fa91bcdaff1f429d178be7c28940b9
|
825.6 kB | Download |
|
md5:a0f9f17bc890f97ed67847a738024880
|
359.9 kB | Download |
|
md5:fd24a9d527d5ee43437108c2f0696311
|
91.1 kB | Download |
|
md5:c0e19f764f3834d2dfe738c9d92ed3ea
|
94.7 kB | Download |
|
md5:44b4a87cd961deedf2ff7b7c82e4779c
|
7.8 MB | Download |
|
md5:57180fd46e94f75fffe4ba52d97ef83b
|
373.9 kB | Download |
|
md5:a6a6d65e9d918d2ba29e4e39cfa2b080
|
129.3 kB | Download |
|
md5:608eda6facd137aaf891c39180f95ba1
|
719.5 kB | Download |
|
md5:ca7f91d8fb9b03fa237c234a6c2e1cd5
|
636.0 kB | Download |
|
md5:0f8e8f16fd2b32765cf6b44191ea8cc8
|
2.5 MB | Download |
|
md5:81e3c086d9a92ecd925d3fd5b9fd3909
|
3.4 MB | Download |
|
md5:5d6c27bcc817c4689c820933d7d670eb
|
5.3 MB | Download |
|
md5:a16af3c769c1476757be75320b2934ed
|
6.5 MB | Download |
|
md5:627163063ebcd2a8be9e02abd05c2fce
|
4.9 MB | Download |
|
md5:a995964d727a97c94340a46537597463
|
326.2 kB | Download |
|
md5:e883a2a6ea9ab8f75908dc9d5eb874ac
|
832.7 kB | Download |
|
md5:98a5471f6ce99ed09fee3ae5cf3ea8ba
|
490.0 kB | Download |
|
md5:62e696dca9899e34c7060d2420a4e0cd
|
1.8 MB | Download |
|
md5:b781bd128ab12916d96c20cf4b6cf9f5
|
657.6 kB | Download |
|
md5:89423a6dd9f2f816ed9362b78c7148ba
|
371.3 kB | Download |
|
md5:3787d9219d73ea072eca713895a5ff71
|
2.4 MB | Download |
|
md5:f8b27cc305a03504b99ef8a14856a55a
|
1.9 MB | Download |
|
md5:b15be589a8909d99020dda0c2c490cba
|
5.1 MB | Download |
|
md5:95edac082cb0061d212019bb6f565e1d
|
380.5 kB | Download |
|
md5:1c2212205def937733197ad2f42eb2cf
|
550.5 kB | Download |
|
md5:519c707fb35daa68c8bdad99d3ea12d0
|
1.1 MB | Download |
|
md5:5c493a75cbef938de387133fd0227131
|
1.9 MB | Download |